NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director
21. Januar 2025 16:20 ET
|
NurExone Biologic Inc
NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy
02. Januar 2025 15:55 ET
|
PMGC Holdings Inc.
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
02. Januar 2025 08:00 ET
|
Carmell Corporation
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
Adia Nutrition Unveils Exclusive Artwork by Renowned Performance Artist Rock Demarco at First Clinic
17. Dezember 2024 09:00 ET
|
ADIA Nutrition
WINTER PARK, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition is excited to announce the installation of an exclusive artwork by the renowned performance artist and speed painter, Rock...
Adia Nutrition Opens Doors in Winter Park, FL, Now Accepting Patients for AHSCT and Regenerative Therapies
10. Dezember 2024 09:00 ET
|
ADIA Nutrition
WINTER PARK, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition is thrilled to announce the opening of its inaugural clinic in Winter Park, Florida. The state-of-the-art facility is now...
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market
06. Dezember 2024 07:30 ET
|
Elevai Labs Inc.
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division
04. Dezember 2024 08:00 ET
|
Elevai Labs Inc.
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division
CORRECTION - Elevai Labs Inc.
14. November 2024 14:35 ET
|
Elevai Labs Inc.
/CORRECTION/ Elevai Labs Inc. Reports Financial Results for the Third Fiscal Quarter of 2024 and Provides Business Update
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
14. November 2024 09:08 ET
|
Elevai Labs Inc.
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
13. November 2024 16:14 ET
|
NurExone Biologic Inc
European Medicines Agency Awards Orphan Status to NurExone's ExoPTEN for Spinal Cord Injury, Paving the Way to European Market Entry